ClinicalTrials.govpublic full text
Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy
acute coronary syndrome (acs), high bleeding risk (hbr), coronary artery disease (cad), dual antiplatelet therapy (dapt), percutaneous coronary intervention (pci), opt-cad score, quality control indicators, coronary revascularization, prospective cohort study, real-world research, bleeding events, ischemic events
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 900842
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.